Vascular News

@VascularNews

The international newspaper for vascular specialists. Subscribe for the latest updates

Global
Vrijeme pridruživanja: studeni 2011.

Tweetovi

Blokirali ste korisnika/cu @VascularNews

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @VascularNews

  1. proslijedio/la je Tweet
    prije 13 sati
    Poništi
  2. prije 16 sati

    Enrolment of the VasQ external support US pivotal study now complete

    Poništi
  3. 4. velj

    IVL has “changed the dynamics” of facilitating EVAR & TEVAR in calcified iliac arteries (Frank Arko) –

    Poništi
  4. proslijedio/la je Tweet
    4. velj

    Combination of scaffold and drug in BTK intervention “without question” the right way forward -

    Poništi
  5. 4. velj

    : BD announced long-term safety data for BTK drug-coated balloon

    Poništi
  6. 3. velj

    Centralisation of aortic surgery is “imperative”

    Poništi
  7. 3. velj

    Merit Medical’s EmboCube embolisation gelatin and Torpedo gelatin foam indicated for embolisation of blood vessels

    Poništi
  8. 3. velj

    : Positive new data for AV access interventions released

    Poništi
  9. 3. velj

    Intact Vascular expands Tack Endovascular System portfolio offering

    Poništi
  10. 3. velj

    : Profusa Lumee oxygen platform may improve the clinical management of patients with CLI

    Poništi
  11. 3. velj

    MedAlliance receives CE mark approval for SELUTION SLR sirolimus drug-eluting balloon for endovascular applications

    Poništi
  12. 3. velj

    : High- and low-dose paclitaxel-coated balloons exhibit comparable results at one-year in COMPARE-RCT

    Poništi
  13. 3. velj

    : Four-year ILLUMENATE data reaffirm safety profile of Stellarex

    Poništi
  14. 3. velj
    Poništi
  15. 30. sij

    Peter Schneider: The prevalence of SAD and no-option CLTI is increasing; promising new alternatives are being explored, including deep venous arterialisation (DVA)

    Poništi
  16. 30. sij

    Marco Manzi: Foot artery canalisation is feasible and useful for wound healing in big artery disease (BAD) patients; small artery disease (SAD) patients “probably need a new approach”

    Poništi
  17. 30. sij

    First-in-man results with the WeFlow Arch: Benefit for lesions involving the arch and ascending aorta, cerebral blood flow affected at each step, but unsuitable for lesions with insufficient ascending landing zone

    Poništi
  18. 30. sij

    Nick Inston: The WavelinQ EndoAVF system offers flexibility for dialysis patients’ future options

    Poništi
  19. 29. sij

    First time release of IN.PACT global 150mm data through three years: 74.5% freedom from CD-TLR and 87.5% freedom from all-cause death

    Poništi
  20. 29. sij

    First time data release on the Turbo Power laser: Heterogeneous and restenotic lesions show greatest increase in MLA from baseline at high laser setting; might be the first step to develop a personalised algorithm to optimise treatment for each patient

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·